Abstract

The feasibility of using cytokeratin antibodies to distinguish nonnal and malignant cells in human tumor biopsies using flow cytometry was tested for increasing the accuracy of cell kinetic measurements. Four different antibodies were screened on a 48 tumors from two centres; 26 head and neck (Amsterdam) and 22 oesophagus (Leuven). First screening was done by immunohistochemistry (ICC) on frozen sections to test staining intensity and fraction of cytokeratin-positive (CK+) tumor cells. The antibody showing the most positive staining was then used for flow cytometry: Two broad spectrum antibodies (AE1/AE3, E3/C4) showed the best results with ICC (>90% tumors positive). Cell suspensions for flow cytometry could be made from frozen material by a mechanical method. Enzymatic methods failed for frozen material but were best for fresh material. Tumor cell enrichment was tested by gating on CK+ cells in flow cytometry using the best antibody. Average enrichment was 0. 58 for head and neck tumors and 0.75 for oesophagus tumors; overall enrichment 0.65 (0 = no enrichment, 1 = pure tumor population). In several cases, 100% enrichment was achieved. We conclude that this method can significantly reduce errors in tumor cell kinetic measurements by reducing nonnal cell “contamination”.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.